| Identification | Back Directory | [Name]
AZD-5582 | [CAS]
1258392-53-8 | [Synonyms]
CS-2673
AZD-5582
AZD5582;AZD-5582;AZD 5582
3,3'-[2,4-Hexadiyne-1,6-diylbis[oxy[(1S,2R)-2,3-dihydro-1H-indene-2,1-diyl]]]bis[N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-L-prolinamide]
L-Prolinamide, 3,3'-[2,4-hexadiyne-1,6-diylbis[oxy[(1S,2R)-2,3-dihydro-1H-indene-2,1-diyl]]]bis[N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-
(S,S,2S,2'S)-N,N'-((1S,1'S,2R,2'R)-(hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1H-indene-2,1-diyl))bis(1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) | [Molecular Formula]
C58H78N8O8 | [MDL Number]
MFCD28411397 | [MOL File]
1258392-53-8.mol | [Molecular Weight]
1015.29 |
| Chemical Properties | Back Directory | [Boiling point ]
1207.3±65.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [storage temp. ]
4°C, protect from light, stored under nitrogen | [solubility ]
DMF: 30 mg/ml; DMSO: 15 mg/ml; Ethanol: 30 mg/ml | [form ]
A crystalline solid | [pka]
12.99±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
It is a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer. |
|
|